title: Should we start population screening for prostate cancer? Randomised trials are still needed.
authors.affiliation: School of Public Health, FIN-33014 University of Tampere, Tampere, Finland. aussi.auvinen@uta.fi
authors.forename: Anssi
authors.initials: A
authors.lastname: Auvinen
authors.forename: Freda E
authors.initials: FE
authors.lastname: Alexander
authors.forename: Harry J
authors.initials: HJ
authors.lastname: de Koning
authors.forename: Anthony B
authors.initials: AB
authors.lastname: Miller
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D008403:Mass Screening; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D013997:Time Factors
chemical_list: D017430:Prostate-Specific Antigen